BDBM694769 US20240294545, Compound A-22

SMILES CC[C@@H]1COc2c(c(F)cc3ncc4n(C)c(=O)n1c4c23)-c1ccc(OCCCN2CCCCC2)nc1

InChI Key InChIKey=QIUHOMNRLMPPFS-UHFFFAOYSA-N

Data  9 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 694769   

TargetSerine-protein kinase ATM(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 0.520nMAssay Description:(1) Preparation of 1× kinase basal buffer and reaction termination solution1) 1× kinase basal buffer50 mM HEPES, pH 7.50.0015% Brij-35 (polyoxyethyle...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 1.00E+4nMAssay Description:(1) Preparation of 1�� kinase buffer and reaction termination solution1) 1�� kinase buffer50 mM HEPES, pH 7.50.0015% Brij-351 M MnCl22) Reaction term...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 1.28E+3nMAssay Description:(1) Preparation of 1× kinase buffer50 mM HEPES, pH 7.51 mM EGTA0.01% Tween-20(2) Preparation of test compound1) The compound was dissolved in DMSO to...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 852nMAssay Description:(1) Preparation of 1× kinase buffer40 mM Tris, pH 7.50.0055% Brij-3520 mM MgCl20.05 mM DTT(2) Preparation of test compound1) The compound was dissolv...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 6.28E+3nMAssay Description:(1) Preparation of 1× kinase buffer50 mM HEPES, pH 7.53 mM MgCl21 mM EGTA100 mM NaCl0.03% CHAPS2 mM DTT(2) Preparation of test compound1) Dissolution...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 1.00E+4nMAssay Description:(1) Preparation of 1× kinase buffer50 mM HEPES, pH 7.53 mM MgCl21 mM EGTA100 mM NaCl0.03% CHAPS2 mM DTT(2) Preparation of test compound1) Dissolution...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 1.00E+4nMAssay Description:(1) Preparation of 1× kinase buffer50 mM HEPES, pH 7.53 mM MgCl21 mM EGTA100 mM NaCl0.03% CHAPS2 mM DTT(2) Preparation of test compound1) Dissolution...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 1.00E+4nMAssay Description:(1) Preparation of 1× kinase buffer50 mM HEPES, pH 7.53 mM MgCl21 mM EGTA100 mM NaCl0.03% CHAPS2 mM DTT(2) Preparation of test compound1) Dissolution...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent

TargetSerine-protein kinase ATM(Human)
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang)

US Patent
LigandPNGBDBM694769(US20240294545, Compound A-22)
Affinity DataIC50: 0.520nMAssay Description:(1) Preparation of 1× kinase basal buffer and reaction termination solution1) 1× kinase basal buffer50 mM HEPES, pH 7.50.0015% Brij-35 (polyoxyethyle...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/21/2024
Entry Details
Go to US Patent